Kepos Capital LP Takes Position in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

Key Points

• Kepos Capital LP recently acquired 55,000 shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC), representing a total investment of approximately $563,000, placing it as the firm's 14th largest position.
• Other institutional investors, including AQR Arbitrage LLC and Toronto Dominion Bank, also made significant investments in OACC during the fourth quarter, indicating growing interest in the company.
• As of now, Oactree Acquisition Corp. III Life Sciences shares are trading around $10.47, with a 52-week range between $9.95 and $10.85.

Kepos Capital LP bought a new position in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) in the first quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 55,000 shares of the company's stock, valued at approximately $563,000. Oaktree Acquisition Corp. III Life Sciences comprises 0.5% of Kepos Capital LP's portfolio, making the stock its 14th largest position. Kepos Capital LP owned approximately 0.25% of Oaktree Acquisition Corp. III Life Sciences as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. AQR Arbitrage LLC acquired a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at about $19,743,000. Toronto Dominion Bank purchased a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at approximately $14,355,000. Shaolin Capital Management LLC purchased a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at approximately $5,478,000. Two Sigma Investments LP purchased a new stake in Oaktree Acquisition Corp. III Life Sciences in the fourth quarter valued at approximately $4,358,000. Finally, Lighthouse Investment Partners LLC purchased a new stake in Oaktree Acquisition Corp. III Life Sciences in the fourth quarter valued at approximately $3,039,000.

Oaktree Acquisition Corp. III Life Sciences Stock Performance

Shares of NASDAQ OACC opened at $10.47 on Thursday. The firm has a 50 day moving average price of $10.48. Oaktree Acquisition Corp. III Life Sciences has a 52-week low of $9.95 and a 52-week high of $10.85.

Oaktree Acquisition Corp. III Life Sciences Profile

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.

Want to see what other hedge funds are holding OACC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.